FundedIQ
Biotechnology

Alcyone Therapeutics: Funding, Investors & Team (Oct 2026)

Alcyone Therapeutics is leading the way in developing advanced precision genetic therapies for the central nervous system, aiming to uncover new opportunities and conquer obstacles in the field of CNS therapy.

alcyonetx.com LinkedIn Lowell, United States 11-50 employees
Biotechnology Therapeutics
Total raised
$23.0M
Rounds
2
Latest
Undisclosed round
Apr 2025

Alcyone Therapeutics has raised $23.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2025.

Alcyone Therapeutics Company Profile and Key Stats

Total funding raised
$23.0M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
Apr 2025
Employees
11-50
reported band
Headquarters
Lowell, United States

Latest funding round on record: Apr 2025.

Alcyone Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Undisclosed round
$23.0M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Alcyone Therapeutics raised $23.0M in an undisclosed round announced in Jun 2021.

3.8 years later, an undisclosed round was announced in Apr 2025 with no disclosed amount.

Alcyone Therapeutics Founders and Leadership Team

Name
Role
Contact
Pj Anand
Founder
Locked

Contact details for the Alcyone Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Alcyone Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Funded Startups Like Alcyone Therapeutics in Biotechnology and Lowell

Companies Similar to Alcyone Therapeutics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Alcyone Therapeutics Funding FAQs

What does Alcyone Therapeutics do?

Alcyone Therapeutics is leading the way in developing advanced precision genetic therapies for the central nervous system, aiming to uncover new opportunities and conquer obstacles in the field of CNS therapy.

How much funding has Alcyone Therapeutics raised?

Alcyone Therapeutics has raised $23.0M across 2 rounds on record.

When did Alcyone Therapeutics last raise funding?

Alcyone Therapeutics' most recent funding round on record was announced in Apr 2025. The amount was not disclosed.

Who founded Alcyone Therapeutics?

FundedIQ lists Pj Anand (Founder) at Alcyone Therapeutics.

Where is Alcyone Therapeutics headquartered?

Alcyone Therapeutics is based in Lowell, Massachusetts, United States.

How many employees does Alcyone Therapeutics have?

Alcyone Therapeutics is in the 11-50 employee band.

About FundedIQ's Alcyone Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alcyone Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.